$ANIX

Anixa Biosciences Inc

1
0
0
$49K
KUMAR AMIT
0%
See all $ANIX insider activity →
Low

KUMAR AMIT purchased $8K of ANIX

KUMAR AMIT (Chief Executive Officer) purchased 3,000 shares of Anixa Biosciences Inc (ANIX) at $2.75 on 2026-09-10.

RedChip Companies, Inc.: Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money Show on CNBC and Bloomberg TV

RedChip Companies will air interviews with Anixa Biosciences (NASDAQ:ANIX) and Nexalin Technology (NASDAQ:NXL) on Bloomberg TV and CNBC. Anixa is developing a breast cancer vaccine, while Nexalin focuses on neurostimulation for mental health. Both companies are preparing for key trials and commercialization efforts.

ANIX sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning ANIX (Anixa Biosciences Inc). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent ANIX coverage spans insider activity, technology and financial news.

In the last 30 days, ANIX insiders filed 3 SEC Form 4 transactions — 3 purchases ($49K) and no sales. The most active reporter was KUMAR AMIT, Chief Executive Officer, with 2 filings.

What's driving ANIX

AlphAI scores every news story that mentions ANIX with an AI model for sentiment and relevance, and aggregates insider trades from Anixa Biosciences Inc's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ANIX

Score
$ANIXMedAI 8/10

RedChip Companies, Inc.: Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money Show on CNBC and Bloomberg TV

RedChip Companies will air interviews with Anixa Biosciences (NASDAQ:ANIX) and Nexalin Technology (NASDAQ:NXL) on Bloomberg TV and CNBC. Anixa is developing a breast cancer vaccine, while Nexalin focuses on neurostimulation for mental health. Both companies are preparing for key trials and commercialization efforts.

Monday’s insider activity: Notable buys and sells disclosed

Investing.com reported Monday’s SEC Form 4 insider trades for several US-listed firms. Buys included Hanover Bancorp (HNVR) President Kevin O’Connor buying 10,000 shares at $26.88, Protagenic Therapeutics (PTIX) executive chair buying 26,291 shares at $0.1828, and V F Corp (VFC) CEO buying 32,894 shares at ~$14.98. Sales included Snowflake (SNOW) EVP selling 29,986 shares at $300 and Cactus (WHD) leaders selling 86,700 shares each at $57.618.

Related tickers